GHRH analog raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-10-04. Anything still debated is marked as such rather than presented as settled.
Verification matters because research peptides vary widely in quality. A certificate of analysis is only as reliable as the method behind it, and a single chromatographic trace reveals little about counter-ions, residual solvents, or water content. Independent laboratories commonly pair mass confirmation with chromatographic purity and, where relevant, quantify water along with acetate or trifluoroacetate content. Reported purity figures are not standardized across suppliers, so a stated value such as ninety-eight percent is not directly comparable unless the analytical method, column, and detection wavelength accompany it.
Characterization of this peptide relies on a small set of routine techniques. Reversed-phase high-performance liquid chromatography separates the target from truncated or oxidized by-products and yields a purity estimate when paired with ultraviolet detection near 214 nanometers. Mass spectrometry, either electrospray coupled to liquid chromatography or matrix-assisted laser desorption, confirms that the observed mass matches the value calculated for the expected sequence. Amino acid analysis, and enzymatic digestion followed by fragment mapping, are used when the sequence itself rather than the mass requires verification.
Stability depends heavily on physical state. A lyophilized powder kept dry, desiccated, and shielded from light typically holds its integrity for months to years at minus twenty degrees Celsius, and longer at minus eighty. Once dissolved, the peptide becomes far more vulnerable, since peptide bond hydrolysis, oxidation of susceptible residues, and aggregation all proceed faster in solution. Buffers near neutral pH are generally gentler than strongly acidic or alkaline conditions. Repeated freeze-thaw cycles and exposure to air-liquid interfaces during vigorous mixing cause losses that are easy to overlook.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Assessed by visual inspection under ordinary light |
| Primary analytical method | Reversed-phase liquid chromatography | Purity estimated from peak area at 214 nm |
| Confirmatory method | Mass spectrometry | Observed mass compared with calculated value |
| Powder storage temperature | Minus 20 degrees Celsius | Minus 80 for extended archival periods |
| Solution stability | Hours to days at 2 to 8 degrees Celsius | Influenced by pH, buffer, and concentration |
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.
Reverse-phase high-performance liquid chromatography is the standard tool for purity assessment. The technique separates the target peptide from truncated or modified byproducts. Mass spectrometry confirms molecular weight and supports sequence verification. Electrospray ionization and matrix-assisted laser desorption are both used. Amino acid analysis provides an independent check on composition. Purity values are commonly reported as area percentage from the chromatogram. Residual trifluoroacetate and water content are also measured in many quality programs.
Batch-to-batch consistency depends on solid-phase peptide synthesis and subsequent purification. Coupling efficiency, resin choice, and cleavage conditions all affect the final profile. Counter-ion content and moisture can shift the apparent mass of a batch. Documentation typically includes a certificate of analysis with chromatograms and spectra. Independent verification by a second laboratory is sometimes requested. Whether a given certificate reflects the actual vial contents depends on chain of custody. Analytical methods themselves carry uncertainty that should be stated alongside results.
Lyophilized material is typically stored at minus twenty degrees Celsius or lower. Keeping the vial dry and protected from light preserves peptide integrity. Repeated freeze-thaw cycles can cause aggregation or loss of activity. Once dissolved, solutions are generally kept at two to eight degrees Celsius. Stability data for reconstituted solutions vary, and long-term behavior is not fully established. Working aliquots reduce the number of times a stock container is opened.
=== Molecular Weight === Since the molecular weight (or extent of polymerization) of a solute will correspond to a specific refractive index increment, the relationship between increasing solute weight and refractive index increment can be plotted to determine the exact molecular weight of an unknown solute.
== Early views == In the 4th century BC, the Greek philosopher Plato argued that love directs the bonds of human society. In his Symposium, Eryximachus, one of the narrators in the dialog, states that love goes far beyond simple attraction to human beauty. He states that it occurs throughout the animal and plant kingdoms, as well as throughout the universe. Love directs everything that occurs, in the realm of the gods as well as that of humans (186a–b). Eryximachus reasons that when various opposing elements such as wet and dry are "animated by the proper species of Love, they are in harmony with one another... But when the sort of Love that is crude and impulsive controls the seasons, he brings death and destruction" (188a). Because it is love that guides the relations between these sets of opposites throughout existence, in every case it is the higher form of love that brings harmony and cleaves toward the good, whereas the impulsive vulgar love creates disharmony. Plato concludes that the highest form of love is the greatest. When love "is directed, in temperance and justice, towards the good, whether in heaven or on earth: happiness and good fortune, the bonds of human society, concord with the gods above—all these are among his gifts" (188d). In the 1660s, the Dutch philosopher Spinoza wrote, in his Ethics of Human Bondage or the Strength of the Emotions, that the term bondage relates to the human infirmity in moderating and checking the emotions.
==== Response and investigation ==== News of Biko's death spread quickly across the world, and became symbolic of the abuses of the apartheid system. His death attracted more global attention than he had ever attained during his lifetime. Protest meetings were held in several cities; many were shocked that the security authorities would kill such a prominent dissident leader. Biko's Anglican funeral service, held on 25 September 1977 at King William's Town's Victoria Stadium, took five hours and was attended by around 20,000 people. The vast majority were black, but a few hundred whites also attended, including Biko's friends, such as Russell and Woods, and prominent progressive figures like Helen Suzman, Alex Boraine, and Zach de Beer. Foreign diplomats from thirteen nations were present, as was an Anglican delegation headed by Bishop Desmond Tutu. The event was later described as "the first mass political funeral in the country". Biko's coffin had been decorated with the motifs of a clenched black fist, the African continent, and the statement "One Azania, One Nation"; Azania was the name that many activists wanted South Africa to adopt after apartheid. Biko was buried in the cemetery at Ginsberg. Two BCM-affiliated artists, Dikobé Ben Martins and Robin Holmes, produced a T-shirt marking the event; the design was banned the following year. Martins also created a commemorative poster for the funeral, the first in a tradition of funeral posters that proved popular throughout the 1980s.
== History == CIP was first described in 1984 by Charles F. Bolton in a series of five patients. The condition used to be described as "Bolton's neuropathy.". In 1996, Latronico and colleagues first described that CIP and CIM often coexist in the same patient.
See polycythemia vera for management of primary polycythemia, which involves reducing thrombotic risk, symptom amelioration and monitoring for further hematologic complications. Treatment can include phlebotomy, aspirin, and myelosuppressive or cytoreductive medications based on risk stratification. For secondary polycythemia, management involves addressing the underlying etiology of increased erythropoeitin production, such as smoking cessation, CPAP for sleep apnea, or removing any EPO-producing tumours. Phlebotomy is not typically recommended for patients with physiologic polycythemia, who rely on additional red cell mass for necessary oxygen delivery, unless the patient is clearly symptomatic and experiences relief from phlebotomy. It is unclear if patients with secondary polycythemia are at elevated thrombotic risk, but aspirin can be considered for patients at elevated cardiovascular risk or for patients with Chuvash polycythemia. The first-line treatment for post-transplant erythrocytosis specificity is angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers.
Sources: en.wikipedia.org
=== Restriction fragment length polymorphism === Restriction fragment length polymorphism (RFLP) is considered to be the simplest and earliest method to detect SNPs. SNP-RFLP makes use of the many different restriction endonucleases and their high affinity to unique and specific restriction sites. By performing a digestion on a genomic sample and determining fragment lengths through a gel assay it is possible to ascertain whether or not the enzymes cut the expected restriction sites. A failure to cut the genomic sample results in an identifiably larger than expected fragment implying that there is a mutation at the point of the restriction site which is rendering it protection from nuclease activity. The combined factors of the high complexity of most eukaryotic genomes, the requirement for specific endonucleases, the fact that the exact mutation cannot necessarily be resolved in a single experiment, and the slow nature of gel assays make RFLP a poor choice for high throughput analysis.
During his 2022 gubernatorial campaign, Moore criticized the Hogan administration for a "failure of executive leadership" on fighting climate change. He supports the renewable energy goals set by the state's Clean Energy Jobs Act of 2019, which called for a 50% reduction in greenhouse gas emissions and an electrification of the state's vehicle fleet by 2030, and has said the state should pursue "more ambitious goals" beyond carbon neutrality. He also proposed regulations to achieve 100% clean energy use by 2035 and net zero carbon emissions by 2045, electrify the state's fleet, and prioritize environmental-justice funding. Moore also said that he would establish a "cap-and-invest" program in Maryland, which would tax polluters to provide revenue for clean energy infrastructure and relief in communities of color, and promised to hire a "climate czar" in his administration, whom he appointed in November 2023. In July 2025, Moore signed an executive order ordering his administration to utilize the Maryland Department of the Environment's EnviroScreen tool, which allows users to view data on pollution burdens and health metrics by census tract, to inform their policy work and agency decisions. The order also created an interagency advisory council to develop environmental justice strategic plans in collaboration with thirteen state agencies and contained provisions calling on state agencies to accelerate their efforts in removing barriers preventing farmers from accessing land and financing.
UPMC Altoona, located in Altoona, Pennsylvania, is a 361-bed, non-profit, private community hospital system that contains more than 20 affiliated health care companies and functions as the regional referral center and tertiary hub of UPMC in west central Pennsylvania.
Alternatively, HBr and strong Lewis acids have been used, provided that a trap is provided for the released benzyl carbocation. When the protected amine is treated by either of the above methods (i.e. by catalytic hydrogenation or acidic workup), it yields a terminal carbamic acid which then readily decarboxylates to give the free amine. 2-Mercaptoethanol can also be used, in the presence of potassium phosphate in dimethylacetamide.
== Adverse effects == Adverse effects include drowsiness, dizziness, weakness, fatigue, headache, trouble sleeping, nausea and vomiting, poor concentration and recall (resembling dementia), urinary retention, or constipation.
Sources: en.wikipedia.org
Mass spectrometry establishes whether the observed molecular weight matches the calculated sequence mass. Chromatographic retention and fragment mapping add further confidence about sequence and composition. A single technique alone is rarely treated as sufficient evidence of identity.
Dry powder is markedly more stable than solution and is usually held frozen and desiccated. Room temperature exposure over days degrades it more slowly than most people assume, but long-term integrity favors freezer storage. Light protection is recommended regardless of temperature.
Methods, columns, gradients, and detection wavelengths are not standardized across laboratories. Some figures describe only the main peak area at one wavelength and ignore water, salts, or counter-ions. Without stated conditions, comparing reported percentages across sources is unreliable.
It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.